Phlexglobal’s eTMF Solution Supports Synairgen’s Expedited COVID-19 Trial
Phlexglobal, a technology and services provider,has announced that Synairgen, a drug discovery and development company developing therapies for respiratory disease, implemented Phlexglobal’s PhlexTMF SaaS software to support a COVID-19 trial.
After being chosen by Synairgen as the preferred vendor for provision of an eTMF, Phlexglobal implemented its SaaS eTMF software, which includes built-in best practices that aim to improve TMF health, including embedded quality review, event management, wizard-driven completeness, intelligent placeholders, and more. The company’s global team of TMF experts and project managers applied its methodology to go from project kickoff on June 16, 2020, to go-live on July 1, 2020—a total of just 16 days. As part of its ongoing contribution to helping fight the COVID-19 pandemic, Phlexglobal’s corporate commitment is to provide complimentary services.
“Since the outbreak of the COVID-19 pandemic, Phlexglobal has provided extensive support for multiple biopharmaceutical companies developing effective treatments for those who have been impacted by the virus, as well as promising vaccines to prevent its spread,”said John McNeill, Chief Executive Officer of Phlexglobal. “We’re honored to be able to provide critical software and services to help address the most important health crisis facing the world today.”
With 120 home-based and 100 hospital-based patients in the trial, the ease of use of Phlexglobal’s eTMF technology and support services were key factors in Synairgen’s decision.
To read the full release, click here.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
